Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomarker Science, Inc. was a biotechnology company focused on the discovery and development of proteomic-based biomarkers for the early detection and monitoring of diseases, particularly cancer. The company utilized advanced mass spectrometry and protein separation technologies to identify clinical biomarkers from complex biological samples. Founded in 2001 and based in San Jose, California, the company aimed to bridge the gap between proteomic research and clinical diagnostic applications. In 2008, Biomarker Science was acquired by Wako Pure Chemical Industries (now Fujifilm Wako Pure Chemical Corporation) to enhance its diagnostic reagent and biomarker discovery business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomarker Science Company.